![](https://www.diabetesnews.com/wp-content/uploads/2014/07/diabetes-insulin-afrezza-150x150.jpg)
Afrezza is an ultra-rapid-acting powder designed to be taken before a meal. It is designed for adults with type 1 or type 2 diabetes, but it is not yet approved for kids. It’s important to understand that Afrezza is not a stand-alone drug. This novel delivery system was created to control post-meal blood sugar spikes, and should be used with existing insulin treatments.